420 related articles for article (PubMed ID: 16481098)
1. Are we really making an advance in the treatment of metastatic renal cell carcinoma?
Kirkali Z
Eur Urol; 2006 Apr; 49(4):604-5. PubMed ID: 16481098
[No Abstract] [Full Text] [Related]
2. High-dose interleukin-2 in metastatic renal cell carcinoma.
Fernández-Rodríguez R; de Argumedo GL; Mañé JM; Muñoz A; Ferreiro J; Fuente N; López-Vivanco G
J Clin Oncol; 2005 Sep; 23(27):6797-8; author reply 6798-9. PubMed ID: 16170190
[No Abstract] [Full Text] [Related]
3. The role of surgery in advanced renal cell carcinoma: cytoreductive nephrectomy and metastasectomy.
Karam JA; Wood CG
Hematol Oncol Clin North Am; 2011 Aug; 25(4):753-64. PubMed ID: 21763966
[TBL] [Abstract][Full Text] [Related]
4. Presurgical therapy in metastatic renal cell carcinoma.
Jonasch E
Expert Rev Anticancer Ther; 2007 Jan; 7(1):73-8. PubMed ID: 17187521
[TBL] [Abstract][Full Text] [Related]
5. Cytoreductive nephrectomy: past, present and future.
Galazi M; Rodriguez-Vida A; Josephides E; Chau NM; Chowdhury S
Expert Rev Anticancer Ther; 2014 Mar; 14(3):271-7. PubMed ID: 24392671
[TBL] [Abstract][Full Text] [Related]
6. Advances in immune-based therapies of renal cell carcinoma.
Lam JS; Belldegrun AS; Figlin RA
Expert Rev Anticancer Ther; 2004 Dec; 4(6):1081-96. PubMed ID: 15606335
[TBL] [Abstract][Full Text] [Related]
7. Phase II cytotoxic chemotherapy trials in renal cell carcinoma: 1983-1988.
Yagoda A
Prog Clin Biol Res; 1990; 350():227-41. PubMed ID: 2201045
[No Abstract] [Full Text] [Related]
8. [Bilateral synchronous renal cell carcinoma: report of three cases].
Nakatsuji H; Yamashita Y; Karashima T; Hashine K; Sumiyoshi Y
Hinyokika Kiyo; 1999 Oct; 45(10):695-8. PubMed ID: 10586361
[TBL] [Abstract][Full Text] [Related]
9. Current clinical trials in renal cell carcinoma.
Sokoloff MH; Daneshmand S; Ryan CW
Urol Oncol; 2005; 23(4):289-92. PubMed ID: 16018946
[TBL] [Abstract][Full Text] [Related]
10. Modest effect of interferon alfa on metastatic renal-cell carcinoma.
Amato R
Lancet; 1999 Jan; 353(9146):6-7. PubMed ID: 10023941
[No Abstract] [Full Text] [Related]
11. Interferon in metastatic renal cell carcinoma.
Fosså SD
Semin Oncol; 2000 Apr; 27(2):187-93. PubMed ID: 10768597
[TBL] [Abstract][Full Text] [Related]
12. Selecting patients for cytoreductive nephrectomy in advanced renal cell carcinoma: who and when.
Bex A; Powles T
Expert Rev Anticancer Ther; 2012 Jun; 12(6):787-97. PubMed ID: 22716495
[TBL] [Abstract][Full Text] [Related]
13. Multi-modal treatment of primarily using continuous subcutaneous interferon-alpha injection in combination with surgery and/or radiotherapy.
Maruoka M; Fujimura M; Kawamura K; Suzuki S; Hamano M; Nishikawa Y; Nagayama T
Int J Urol; 2005 May; 12(5):442-8. PubMed ID: 15948742
[TBL] [Abstract][Full Text] [Related]
14. The role of cytoreductive nephrectomy in the era of molecular targeted therapy.
Polcari AJ; Gorbonos A; Milner JE; Flanigan RC
Int J Urol; 2009 Mar; 16(3):227-33. PubMed ID: 19207114
[TBL] [Abstract][Full Text] [Related]
15. Metastatic renal cell carcinoma: recent advances in the targeted therapy era.
Di Lorenzo G; Autorino R; Sternberg CN
Eur Urol; 2009 Dec; 56(6):959-71. PubMed ID: 19748725
[TBL] [Abstract][Full Text] [Related]
16. Novel therapeutics for metastatic renal cell carcinoma.
Hutson TE; Figlin RA
Cancer; 2009 May; 115(10 Suppl):2361-7. PubMed ID: 19402059
[TBL] [Abstract][Full Text] [Related]
17. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
Kwan KG; Kapoor A
Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
[TBL] [Abstract][Full Text] [Related]
18. Current status of cytoreductive nephrectomy in metastatic renal cell carcinoma.
Harshman LC; Srinivas S
Expert Rev Anticancer Ther; 2007 Dec; 7(12):1749-61. PubMed ID: 18062749
[TBL] [Abstract][Full Text] [Related]
19. [Cytokine therapy for metastatic renal cell carcinoma].
Eto M; Naito S
Gan To Kagaku Ryoho; 2002 Oct; 29(10):1738-44. PubMed ID: 12402423
[TBL] [Abstract][Full Text] [Related]
20. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer.
Flanigan RC; Salmon SE; Blumenstein BA; Bearman SI; Roy V; McGrath PC; Caton JR; Munshi N; Crawford ED
N Engl J Med; 2001 Dec; 345(23):1655-9. PubMed ID: 11759643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]